APPLICATION
ANDA202058
TYPE
ANDA
ORIGINAL APPROVAL
2011-10-07
LATEST ACTION
2020-01-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ZIDOVUDINEDiscontinued
ZIDOVUDINE 300MG · TABLET · ORAL
Approval history
2020-01-22Labeling · Supplement 14 · standardAP
2020-01-22Labeling · Supplement 9 · standardAP
2013-06-03Labeling · Supplement 3 · standardAP
2013-02-01Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.